We are upgrading the repository! A content freeze is in effect until December 6, 2024. New submissions or changes to existing items will not be allowed during this period. All content already published will remain publicly available for searching and downloading. Updates will be posted in the Website Upgrade 2024 FAQ in the sidebar Help menu. Reach out to escholarship@umassmed.edu with any questions.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Authors
Young, Stephen B.Howard, Allison E.
Illanes, Diego S.
Weber Lebrun, Emily Elise
Hardy, Janet R.
Kambiss, Scott M.
O'Dell, Katherine K.
Zhang, Yan
UMass Chan Affiliations
Department of Medicine, Division of Preventive and Behavioral MedicineDepartment of Obstetrics and Gynecology
Document Type
Journal ArticlePublication Date
2009-11-19Keywords
AdultAged
Aged, 80 and over
Humans
Middle Aged
*Polyethylene Terephthalates
Prospective Studies
*Suburethral Slings
*Surgical Mesh
Urinary Incontinence, Stress
Obstetrics and Gynecology
Metadata
Show full item recordAbstract
OBJECTIVE: The objective of the study was to determine the efficacy of the pubovaginal Mersilene mesh sling (PVMMS) for complicated urodynamic stress incontinence (USI). STUDY DESIGN: Between 1990 and 2008, patients with USI plus an at-risk diagnosis underwent a PVMMS by a single surgeon. They were followed up with urodynamics (UDE) and Pelvic Floor Distress Inventory-short form 20 (PFDI-20). Stratification was in an at-risk hierarchy: intrinsic sphincter deficiency (ISD) greater than recurrent USI (RUSI) greater than USI with chronically increased intraabdominal pressure (CI-IAP). A cough stress test determined objective cure. PFDI question 17 assessed subjective cure. RESULTS: Three hundred six patients with ISD (43.5%), RUSI (26.8%), and CI-IAP (29.7%) had objective cure rates of 89.2% in the short term, 86.7% in the intermediate term, and 91.2% in the long term. A group of 48 patients with both short- and long-term UDEs showed cures of 100% and 91.7%. Long-term objective cure rates were: ISD, 90.5% (n = 21); RUSI, 84.2%, (n = 19); CI-IAP, 100% (n = 17). The mean score of postoperative PFDI question 17 was 0.57 (n = 119). Mean symptom improvement was -2.98 (n = 52; P < .0001). CONCLUSION: We demonstrated PVMMS to be subjectively and objectively effective in long-term treatment of complicated forms of USI.Source
Am J Obstet Gynecol. 2009 Nov;201(5):516.e1-7. Epub 2009 Sep 17. Link to article on publisher's siteDOI
10.1016/j.ajog.2009.07.003Permanent Link to this Item
http://hdl.handle.net/20.500.14038/42758PubMed ID
19762003Related Resources
Link to Article in PubMedae974a485f413a2113503eed53cd6c53
10.1016/j.ajog.2009.07.003